The purposes of this study are 1) to measure the advanced glycation end-product, pentosidine, in the plasma and skin of patients who received either kidney or kidney-pancreas transplants to determine whether its concentration declines after these procedures and 2) to correlate pentosidine levels with glomerular filtration rate and with diabetic complications including peripheral neuropathy and microangiopathy.
Showing the most recent 10 out of 753 publications